Related references
Note: Only part of the references are listed.Iron deficiency in pulmonary arterial hypertension: prevalence and potential usefulness of oral supplementation
Stefano Ghio et al.
ACTA CARDIOLOGICA (2021)
Mendelian randomisation analysis of red cell distribution width in pulmonary arterial hypertension
Anna Ulrich et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Oral iron supplementation with ferric maltol in patients with pulmonary hypertension
Karen M. Olsson et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Intracellular iron deficiency in pulmonary arterial smooth muscle cells induces pulmonary arterial hypertension in mice
Samira Lakhal-Littleton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Iron Deficiency in Heart Failure An Overview
Stephan von Haehling et al.
JACC-HEART FAILURE (2019)
Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis
Stefan D. Anker et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
The crucial impact of iron deficiency definition for the course of precapillary pulmonary hypertension
Thomas Sonnweber et al.
PLOS ONE (2018)
Clinical iron deficiency disturbs normal human responses to hypoxia
Matthew C. Frise et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Iron Homeostasis and Pulmonary Hypertension Iron Deficiency Leads to Pulmonary Vascular Remodeling in the Rat
Emanuele Cotroneo et al.
CIRCULATION RESEARCH (2015)
Intravenous iron therapy in patients with idiopathic pulmonary arterial hypertension and iron deficiency
Gerrina Ruiter et al.
PULMONARY CIRCULATION (2015)
Ferric carboxymaltose improves exercise capacity and quality of life in patients with pulmonary arterial hypertension and iron deficiency: A pilot study
Thomas Viethen et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
Supplementation of iron in pulmonary hypertension: Rationale and design of a phase II clinical trial in idiopathic pulmonary arterial hypertension
Luke S. G. E. Howard et al.
PULMONARY CIRCULATION (2013)
Iron deficiency is common in idiopathic pulmonary arterial hypertension
G. Ruiter et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Iron Deficiency and Raised Hepcidin in Idiopathic Pulmonary Arterial Hypertension Clinical Prevalence, Outcomes, and Mechanistic Insights
Christopher J. Rhodes et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Unexplained iron deficiency in idiopathic and heritable pulmonary arterial hypertension
Elaine Soon et al.
THORAX (2011)
Guidelines for the diagnosis and treatment of pulmonary hypertension
Nazzareno Galie et al.
EUROPEAN HEART JOURNAL (2009)
Effects of Iron Supplementation and Depletion on Hypoxic Pulmonary Hypertension Two Randomized Controlled Trials
Thomas G. Smith et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Pulmonary hypertension
Gorev Grubu Uyeleri et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2009)
The increase in pulmonary arterial pressure caused by hypoxia depends on iron status
Thomas G. Smith et al.
JOURNAL OF PHYSIOLOGY-LONDON (2008)
Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency
Darlington O. Okonko et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR): A measure of health-related quality of life and quality of life for patients with pulmonary hypertension
S McKenna et al.
QUALITY OF LIFE RESEARCH (2006)
ATS/ACCP statement on cardiopulmonary exercise testing
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
The ratio of serum transferrin receptor and serum ferritin in the diagnosis of iron status
BI Malope et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Share Paper
